It should be noted that the effective usage of Timp1-targeted constructions, such as siRNA and shRNA, for the treatment of liver fibrosis [104,118] and other diseases accompanied by an imbalance in the synthesis/degradation of ECM components, such as keloids, was shown [119]. Here, TIMP1 is linked to keloid.